QTTB
Price
$1.66
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
20.13M
STOK
Price
$9.48
Change
-$0.00 (-0.00%)
Updated
May 22 closing price
Capitalization
518.67M
80 days until earnings call
Interact to see
Advertisement

QTTB vs STOK

Header iconQTTB vs STOK Comparison
Open Charts QTTB vs STOKBanner chart's image
Q32 Bio
Price$1.66
Change-$0.00 (-0.00%)
Volume$98
Capitalization20.13M
Stoke Therapeutics
Price$9.48
Change-$0.00 (-0.00%)
Volume$3.5K
Capitalization518.67M
QTTB vs STOK Comparison Chart
Loading...
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
QTTB vs. STOK commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QTTB is a Hold and STOK is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (QTTB: $1.66 vs. STOK: $9.48)
Brand notoriety: QTTB and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: QTTB: 0% vs. STOK: 0%
Market capitalization -- QTTB: $20.13M vs. STOK: $518.67M
QTTB [@Biotechnology] is valued at $20.13M. STOK’s [@Biotechnology] market capitalization is $518.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.46B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

QTTB’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 0 green FA rating(s).

  • QTTB’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 0 green, 5 red.
According to our system of comparison, STOK is a better buy in the long-term than QTTB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

QTTB’s TA Score shows that 3 TA indicator(s) are bullish while STOK’s TA Score has 5 bullish TA indicator(s).

  • QTTB’s TA Score: 3 bullish, 3 bearish.
  • STOK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both QTTB and STOK are a good buy in the short-term.

Price Growth

QTTB (@Biotechnology) experienced а -4.60% price change this week, while STOK (@Biotechnology) price change was -1.56% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.00%. For the same industry, the average monthly price growth was +5.57%, and the average quarterly price growth was -1.69%.

Reported Earning Dates

QTTB is expected to report earnings on Mar 11, 2025.

STOK is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+3.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
STOK($519M) has a higher market cap than QTTB($20.1M). STOK YTD gains are higher at: -14.053 vs. QTTB (-51.744). QTTB has higher annual earnings (EBITDA): -44.5M vs. STOK (-115.03M). STOK has more cash in the bank: 239M vs. QTTB (78M). STOK has less debt than QTTB: STOK (2.3M) vs QTTB (18.9M). STOK has higher revenues than QTTB: STOK (16.7M) vs QTTB (0).
QTTBSTOKQTTB / STOK
Capitalization20.1M519M4%
EBITDA-44.5M-115.03M39%
Gain YTD-51.744-14.053368%
P/E RatioN/A11.59-
Revenue016.7M-
Total Cash78M239M33%
Total Debt18.9M2.3M822%
FUNDAMENTALS RATINGS
QTTB vs STOK: Fundamental Ratings
QTTB
STOK
OUTLOOK RATING
1..100
623
VALUATION
overvalued / fair valued / undervalued
1..100
48
Fair valued
50
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10094
PRICE GROWTH RATING
1..100
9557
P/E GROWTH RATING
1..100
10054
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

QTTB's Valuation (48) in the null industry is in the same range as STOK (50). This means that QTTB’s stock grew similarly to STOK’s over the last 12 months.

QTTB's Profit vs Risk Rating (100) in the null industry is in the same range as STOK (100). This means that QTTB’s stock grew similarly to STOK’s over the last 12 months.

STOK's SMR Rating (94) in the null industry is in the same range as QTTB (100). This means that STOK’s stock grew similarly to QTTB’s over the last 12 months.

STOK's Price Growth Rating (57) in the null industry is somewhat better than the same rating for QTTB (95). This means that STOK’s stock grew somewhat faster than QTTB’s over the last 12 months.

STOK's P/E Growth Rating (54) in the null industry is somewhat better than the same rating for QTTB (100). This means that STOK’s stock grew somewhat faster than QTTB’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
QTTBSTOK
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
72%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
83%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
75%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
81%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 8 days ago
84%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 17 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bullish Trend 1 day ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
QTTB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TSOPX14.83N/A
N/A
Nuveen International Res Eq Prmr
VTARX10.91N/A
N/A
Virtus Tactical Allocation R6
HSAFX9.91N/A
N/A
Hussman Strategic Allocation
VBPIX21.23N/A
N/A
Vanguard Baillie GiffordGlbPstvImpStkInv
CSDIX17.31-0.10
-0.57%
Cohen & Steers Real Estate Securities I

QTTB and

Correlation & Price change

A.I.dvisor indicates that over the last year, QTTB has been closely correlated with CLRB. These tickers have moved in lockstep 76% of the time. This A.I.-generated data suggests there is a high statistical probability that if QTTB jumps, then CLRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QTTB
1D Price
Change %
QTTB100%
N/A
CLRB - QTTB
76%
Closely correlated
N/A
MESO - QTTB
51%
Loosely correlated
-3.82%
STOK - QTTB
49%
Loosely correlated
N/A
ADCT - QTTB
47%
Loosely correlated
+13.20%
ANAB - QTTB
43%
Loosely correlated
N/A
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with RCKT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then RCKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
N/A
RCKT - STOK
52%
Loosely correlated
N/A
IDYA - STOK
52%
Loosely correlated
N/A
RNA - STOK
52%
Loosely correlated
N/A
QTTB - STOK
49%
Loosely correlated
N/A
KYMR - STOK
48%
Loosely correlated
N/A
More